Breaking News

Clinipace Completes Choice Pharma Merger

Expands global footprint in Asia

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Clinipace Worldwide has completed the merger with Choice Pharma, a Pan-Asian CRO, extending its global footprint to include 20 operational offices in 15 countries, including new offices in Taiwan, China, Hong Kong, South Korea, Vietnam, Singapore, and Malaysia. According to the company, there are no layoffs or office closings planned. Terms of the transaction were not disclosed. The combined company offers global clinical development services, along with product development, regulatory, and Gx...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters